Donovan Joanne M.
CMO
Donovan Joanne M. has filed 5 SEC Form 4 filings (16 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.
On the most recent filing, Donovan Joanne M. is listed as CMO at Edgewise Therapeutics, Inc. Inside the rolling window, Donovan Joanne M. reported no open-market purchases and 7 open-market sales totaling $4.6M in EWTX. The largest disclosed transaction in the window is a sale of 50,000 EWTX shares on May 5, 2026, worth $1.9M.
Companies traded
Other insiders at EWTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Donovan Joanne M. made?
Donovan Joanne M. has filed 5 SEC Form 4 filings (16 transaction rows) across 1 company since 2026.
Which companies does Donovan Joanne M. trade?
Donovan Joanne M. has filed SEC Form 4 disclosures for 1 company, including EWTX.
When was Donovan Joanne M.'s most recent SEC Form 4 filing?
Donovan Joanne M.'s most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.
What is Donovan Joanne M.'s job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Donovan Joanne M. is listed as CMO.
What is Donovan Joanne M.'s total buy and sell value in the current window?
Inside the rolling retention window, Donovan Joanne M. bought $0 and sold $4.6M based on SEC Form 4 filings.
What was Donovan Joanne M.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 50,000 EWTX shares on 2026-05-05, worth $1.9M, per SEC Form 4 filings.